Down Syndrome and COVID-19: A Perfect Storm?

Area of Science:

• Immunology
• Genetics
• Infectious Disease

Background:

• Individuals with Down syndrome exhibit chronic immune dysregulation, including higher rates of autoimmune disorders and severe respiratory infections.
• Molecular and cellular immune markers in Down syndrome show chronic autoinflammation, such as interferon hyperactivity and elevated inflammatory cytokines.

Purpose of the Study:

• To evaluate the potential impact of immune dysregulation in Down syndrome on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and COVID-19 outcomes.
• To identify individuals with Down syndrome as a high-risk population for severe COVID-19.

Main Methods:

• This perspective synthesizes existing knowledge on immune function in Down syndrome and its potential implications for viral infections.
• It reviews molecular and cellular immune markers associated with chronic inflammation in this population.

Main Results:

• The immune dysregulation in Down syndrome may predispose individuals to an exacerbated cytokine release syndrome during SARS-CoV-2 infection.
• This heightened inflammatory response could lead to more severe COVID-19 outcomes compared to the general population.

Conclusions:

• Individuals with Down syndrome should be considered an at-risk group for severe COVID-19 due to their unique immune profile.
• Additional monitoring and specialized care are warranted for this vulnerable population during the COVID-19 pandemic.